Aug 6 (Reuters)-
Garna Biosciences Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2018 Jun 30, 2017 Dec 31, 2018
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 399 mln 326 mln 1.19
(+22.1 pct) (-26.2 pct) (+81.1 pct)
Operating loss 436 mln loss 291 mln loss 679 mln
Recurring loss 443 mln loss 297 mln loss 694 mln
Net loss 489 mln loss 316 mln loss 758 mln
EPS loss 51.17 yen loss 34.03 yen loss 79.39 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Garna Biosciences Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T